Formulations of vancomycin
AssigneeSciDose Pharma LLC
InventorsNagesh R. Palepu, Philip Christopher Buxton
Life of this patent
Estimating the term…
Abstract
Liquid vancomycin containing compositions having extended shelf life are disclosed. The compositions contain vancomycin or a pharmaceutically acceptable salt thereof, a polyol such as glycerol, and lactic acid or a lactate. The compositions are ready to use and easily transferred into larger parenteral solutions prior to administration to patients in need thereof.
Claims14
A method of providing a dose of a liquid vancomycin-containing composition, comprising:
- a) providing a liquid vancomycin-containing composition, comprising about 200 mg/mL of vancomycin or a pharmaceutically acceptable salt thereof, about 25 to 30% (v/v) glycerol, a member of the group consisting of lactic acid, lactate or mixtures thereof, a base and water, the liquid vancomycin composition having a pH of from about 4.5 to about 7.5;
- and
- b) diluting the liquid vancomycin-containing composition with a pharmaceutically acceptable liquid to concentration of about 5 mg/ml of vancomycin.
A kit comprising at least one pharmaceutically acceptable vial or container containing a liquid vancomycin-containing composition, comprising about 200 mg/mL of vancomycin or a pharmaceutically acceptable salt thereof, about 25 to 30% (v/v) glycerol, a member of the group consisting of lactic acid, lactate or mixtures thereof, a base and water, the liquid vancomycin composition having a pH of from about 4.5 to about 7.5, and optionally a) instructions for use thereof in mammals and/or b) an infusion bag or container containing a pharmaceutically acceptable diluent.
Dependencies are inferred from the claim text.